Africa

Global Advocacy • Education • Support

Allo Hope Africa

Improving awareness, prevention, and access to care for families affected by Rh disease and HDFN across Africa.

Every mother deserves access to the information, support, and medical care needed to protect her baby. Through education, patient advocacy, and collaboration with healthcare providers, Allo Hope Africa is working to make that possible.

Join Our Africa Support Group →
Allo Hope Africa community advocacy

Why This Work Matters

Closing the Gap in Rh Disease Prevention and Care

Rh disease, also known as hemolytic disease of the fetus and newborn (HDFN), can have devastating consequences when appropriate prevention, monitoring, and treatment are unavailable.

An estimated half of the women worldwide who need Rh immune globulin (RhIG) to prevent anti-D alloimmunization do not receive it. This represents approximately three million women annually, with a substantial burden in Sub-Saharan Africa and South Asia.

In many communities, limited access to RhIG, antibody screening, specialized prenatal care, and treatment for HDFN places families at unnecessary risk.

Prevention and Early Diagnosis Matter

RhIG can prevent anti-D alloimmunization in eligible, unsensitized patients. For women who have already developed antibodies, timely diagnosis, appropriate monitoring, and access to experienced providers can make a lifesaving difference.

Advocacy on the Ground

Building Hope in Kenya and Beyond

Rose Murage, Allo Hope Foundation's ambassador in Kenya, is helping lead efforts to improve education, awareness, and support for women affected by Rh disease.

Through community outreach, patient education, and connections with healthcare providers, Rose is helping families better understand Rh incompatibility, the importance of prevention, and the care available for affected pregnancies.

Although access to specialized HDFN care remains challenging in Kenya, we are encouraged by improvements in care and by the dedication of clinicians working to support these families.

Allo Hope Foundation has established relationships with physicians who are committed to improving outcomes and can help connect patients with experienced providers when high-risk care is needed.

Our goal is to ensure that more women know their blood type, understand their risks, and have access to the information and support they need throughout pregnancy.

You Are Not Alone

Connect With Our Africa Support Group

Connect with other women and families navigating Rh incompatibility, alloimmunization, and HDFN. Our community offers a place to share experiences, ask questions, find educational resources, and support one another.

Join the Support Group →

Free Educational Materials

Rh Disease Resources for Families and Communities

Education is an important part of preventing Rh disease and improving outcomes for affected families. These resources were developed to help women understand their blood type, Rh incompatibility, prevention, and the importance of appropriate medical care.

Rh Disease Educational Booklet

A more comprehensive educational guide covering blood types, Rh incompatibility, prevention, diagnosis, and the importance of accessing appropriate care. Ideal for families who want to learn more about Rh disease.

View Educational Booklet →

Rh Disease Educational Flier

A concise, shareable resource explaining why knowing your blood type matters, the importance of RhIG prevention, and where to find help. Designed for community education, patient outreach, and sharing with healthcare providers.

View Educational Flier →

The Allo Podcast cover art

Global Podcast Resources

The experience of navigating alloimmunization and HDFN can look very different depending on where a family lives. Access to prevention, specialized monitoring, and lifesaving treatment varies widely around the world. Through conversations with families and advocates, The Allo Podcast explores the realities and challenges faced by families in different countries and the importance of expanding access to education and treatment worldwide.

Back to Top
Translate »